SNCA and Parkinson disease: Additionally, Chen and colleagues examined the mechanism by which SNCA operates in the nucleus using neurons derived from human-induced pluripotent stem cells from Parkinson's disease patients with A53T and SNCA-triplication autosomal dominant mutations, as well as their CRISPR-edited corrected counterparts.